Smoking Cessation within the Context of Lung Cancer Screening Awards Announced
The National Cancer Institute (NCI) has awarded six grants to support research on the design and implementation of smoking cessation interventions in lung cancer screening settings (RFA-CA-15-011). NCI plans to provide a total of $18.4 million to support the projects for five years. In 2013, the United States Preventive Services Task Force recommended adults ages 55-80 with a 30 pack-year smoking history (who currently smoke or have quit in the past 15 years) undergo annual low-dose computed tomography (LDCT) lung cancer screening. Smoking cessation treatment during LDCT screening offers great potential to reduce tobacco use rates and smoking-related morbidity and mortality. Smoking and exposure to tobacco smoke cause more than 440,000 premature deaths from cancer, heart disease, stroke, and lung disease in the United States each year.
- Paul Cinciripini, Ph.D., University of Texas MD Anderson Cancer Center, Optimizing Effectiveness of Smoking Cessation Intervention During LDCT screening for Lung Cancer (CA207078)
- Kristie Foley, Ph.D., and Caroline Chiles, M.D., Wake Forest University Health Sciences, Implementation of Smoking Cessation Services within NCI NCORP Community Sites with Organized Lung Cancer Screening Programs (CA207158)
- Taylor Hays, M.D., and David Midthun, M.D., Mayo Clinic Rochester, Smoking Cessation in Lung Cancer Screening: Integrated Digital/Clinical Approach (CA207048)
- Jamie Ostroff, Ph.D., and Donna Shelley, M.D., Memorial Sloan Kettering Cancer Center, Optimizing Tobacco Treatment for Smokers Seeking Lung Cancer Screening (CA207442)
- Kathryn Taylor, Ph.D., Georgetown University, Integrating Evidence-Based Smoking Cessation Interventions into Lung Cancer Screening Programs: A Randomized Trial (CA207228)
- Benjamin Toll, Ph.D., Medical University of South Carolina, Gain-framed Messages and NRT Sampling to Promote Smoking Cessation in Lung Cancer Screening Programs (CA207229)
The newly funded grants will advance scientific understanding of the components and characteristics of effective smoking cessation interventions in the lung cancer screening setting, and will provide models for the implementation of evidence-based cessation interventions in screening settings across the nation.
For more information about the Tobacco Control Research Branch, within the NCI Behavioral Research Program, visit: https://cancercontrol.cancer.gov/brp/tcrb/.